Increased risk for coeliac disease in paediatric patients with migraine

F Alehan1, F Ozçay, I Erol

  • 1Divisions of Child Neurology, Baskent University of Medicine, Ankara, Turkey. falehan@hotmail.com

Insights

This study found a higher prevalence of coeliac disease (CD) markers in children with migraine. These findings suggest a potential link between paediatric migraine and CD.

Area of Science:

  • Neurology
  • Gastroenterology
  • Immunology

Background:

  • Migraine is a common neurological disorder in children.
  • Coeliac disease (CD) is an autoimmune disorder triggered by gluten.
  • The association between paediatric migraine and CD requires further investigation.

Purpose of the Study:

  • To investigate the prevalence of coeliac disease (CD) in paediatric patients experiencing migraine.
  • To assess the presence of serum tissue transglutaminase IgA (tTGA) antibodies in children with migraine.

Main Methods:

  • Serum tTGA antibody and IgA levels were measured in 73 paediatric migraine patients and 147 controls.
  • Patients with positive tTGA antibodies underwent duodenal biopsy for histological confirmation.
  • Prevalence rates were compared between the study and control groups.

Main Results:

  • Four (5.5%) paediatric migraine patients and one (0.6%) control subject had positive tTGA antibody titres (P < 0.05).
  • Three migraine patients with positive tTGA antibodies showed normal duodenal histology, indicating potential CD.
  • One patient in each group declined biopsy.

Conclusions:

  • A higher prevalence of tTGA antibodies was observed in paediatric migraine patients compared to controls.
  • The findings suggest a potential association between migraine and coeliac disease in children.
  • Further research is warranted to elucidate the relationship between these conditions.

Related Concept Videos

Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...